Skip to main content
. 2017 Jan 27;8(10):16445–16455. doi: 10.18632/oncotarget.14860

Figure 4. Sensitivity analysis in this meta-analysis.

Figure 4

(A) Sensitivity analysis for the reduced E-cadherin expression with OS. (B) Sensitivity analysis for the reduced E-cadherin expression with DFS.